The latest biotechnology news | Bio News
gene therapy redosing

BIO experts discuss challenges and offer opportunities for developing redosable gene therapies

As drug makers work to develop safe, effective gene therapies, their progress can ...
Read More
SBIR Partnering

BIO 2025: Federal seed funding also comes with valuable advice

The federal government’s program that provides seed funding to support research by biotech ...
Read More
IRA litigation

BIO 2025: Legal experts break down cases against IRA price controls

Litigation opposing drug price controls in the Inflation Reduction Act (IRA) has yet ...
Read More
Magnifier focusing on a financial data analysis graph. Selective focus. Horizontal composition with copy space.

Emerging biotechs get bearish to weather market trends, finds BIO report

“Small companies are the lifeblood of the industry and a lot of what ...
Read More
National Alliance of State Prostate Cancer Coalitions (NASPCC)

Three questions men can ask about prostate cancer

Prostate cancer is the most common solid cancer among men, with 1 in ...
Read More
BOTAR Richmond

BIO visit shines a spotlight on Virginia’s biotech ecosystem

With more than $1 billion in R&D expenditures in 2022 and 415 new ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

Fritz Bittenbender

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More

LATEST NEWS

Federal Policy

BIO experts discuss challenges and offer opportunities for developing redosable gene therapies

As drug makers work to develop safe, effective gene therapies, their progress can be slowed when they challenge the limits of established regulatory guidance on ...
Federal Policy

BIO 2025: Federal seed funding also comes with valuable advice

The federal government’s program that provides seed funding to support research by biotech startups provides much more than money, said program officials and small biotechs ...
BIO Events

BIO 2025: Legal experts break down cases against IRA price controls

Litigation opposing drug price controls in the Inflation Reduction Act (IRA) has yet to have a major impact, but the cases are still ongoing and ...
BIO Events

Emerging biotechs get bearish to weather market trends, finds BIO report

“Small companies are the lifeblood of the industry and a lot of what they do, and what they’re experiencing, greatly affects the industry as a ...
Health

Three questions men can ask about prostate cancer

Prostate cancer is the most common solid cancer among men, with 1 in 8 men being diagnosed in their lifetime and 1 in 44 dying ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

State Policy

International

Bio's View

Scroll to Top